Results 1 to 10 of about 44,698 (310)

The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know?

open access: yesFrontiers in Physiology, 2013
Erythropoietin (EPO) primarily activates erythroid cell proliferation and growth and is active in several types of non-hematopoietic cells via its interaction with the EPO-receptor (EPO-R). This review focuses on the role of EPO in skeletal muscle.
Severine Lamon   +2 more
exaly   +3 more sources

Effectivity of Erythropoietin-Alpha between Fixed- and Adjusted-Dose in Chronic Kidney Disease Patients With Anemia on Hemodialysis

open access: yesFolia Medica Indonesiana, 2021
Anemia is a common complication in chronic kidney disease (CKD) patient with hemodialysis. The cause of anemia is mainly due to erythropoetin deficiency because the kidneys as a erythropoetin producer are damaged.
Mida Purwiningtyas   +3 more
doaj   +1 more source

Breaking the crosstalk of the Cellular Tumorigenic Network by low-dose combination therapy in lung cancer patient-derived xenografts

open access: yesCommunications Biology, 2022
The identification of novel therapeutic strategies for advanced non-small cell lung cancer (NSCLC) is essential as the outcome of most of these patients is poor.
Dennis Gürgen   +6 more
doaj   +1 more source

Evaluation of erythropoietin therapy in hemodialysis patients at PKU Muhammadiyah Hospital Yogyakarta [PDF]

open access: yesPharmaciana, 2018
Most of the patients with end-stage renal disease who undergo hemodialysis receive erythropoietin (EPO) therapy for anemia treatment. Anemia with EPO deficiency is a common complication of chronic kidney disease (CKD).
Adnan Adnan   +2 more
doaj   +1 more source

“Polish People Are Starting to Hate Polish People”—Uncovering Emergent Patterns of Electoral Hostility in Post-Communist Europe

open access: yesSocieties, 2022
Like many societies, Poland seems to be increasingly split by the negative feelings many of its citizens feel towards one another because of the ways in which they vote. This phenomenon is known as electoral hostility.
Anne-Sophie Neyra
doaj   +1 more source

EPOS [PDF]

open access: yesEPJ Web of Conferences, 2019
We summarize the main features of the hadronic interaction model EPOS, which is used for cosmic ray air shower simulations but also for p-p, p-A, and A-A collisions to be compared with experimental data from LHC and RHIC.
Werner, Klaus   +5 more
openaire   +5 more sources

EPO rs1617640 A>C is a Protective Factor for Chronic Obstructive Pulmonary Disease: A Case Control Study

open access: yesFrontiers in Bioscience-Landmark, 2023
Background: The occurrence and development of chronic obstructive pulmonary disease (COPD) are regulated by environmental and genetic factors. In hypoxia, Erythropoietin (EPO) satisfies the body’s need for oxygen by promoting the production of red blood ...
Yunchao Wang   +13 more
doaj   +1 more source

Industrial application requirement in patent law (comparative study) [PDF]

open access: yesپژوهش تطبیقی حقوق اسلام و غرب, 2016
The Subjects that have special industrial application, are capable for registering as invention. Industrial application means that the invention is applicable in specific field of economic activities.
Mahmoud sadeghi, Hamed najafi
doaj   +1 more source

Brexit – The Consequences for Pharmaceutical Patents and Supplementary Protection Certificates

open access: yesBritish Journal of Pharmacy, 2021
Now that the UK has left the EU, and the transition period following this departure is over, we have a clearer view on the implications of Brexit on intellectual property rights and the consequences for UK based pharmaceutical companies. Although little
Harry Melville O'Brien   +2 more
doaj   +1 more source

Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine

open access: yesNeoplasia: An International Journal for Oncology Research, 2021
Patient-derived xenograft (PDX) tumor models represent a valuable platform for identifying new biomarkers and novel targets, to evaluate therapy response and resistance mechanisms.
Maria Rivera   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy